These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7669637)

  • 21. Association of p53 Arg72Pro polymorphism and beta-catenin accumulation in mycosis fungoides.
    Bellei B; Cota C; Amantea A; Muscardin L; Picardo M
    Br J Dermatol; 2006 Dec; 155(6):1223-9. PubMed ID: 17107393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical characterisation of cutaneous lymphomas other than mycosis fungoides.
    Ralfkiaer E; Saati TA; Bosq J; Delsol G; Gatter KC; Mason DY
    J Clin Pathol; 1986 May; 39(5):553-63. PubMed ID: 3522633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas.
    Nikolova M; Bagot M; Boumsell L; Bensussan A
    Leuk Lymphoma; 2002 Apr; 43(4):741-6. PubMed ID: 12153159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.
    Der-Petrossian M; Valencak J; Jonak C; Klosner G; Dani T; Müllauer L; Pehamberger H; Knobler R; Trautinger F
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):922-7. PubMed ID: 21054571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression.
    Li G; Chooback L; Wolfe JT; Rook AH; Felix CA; Lessin SR; Salhany KE
    J Invest Dermatol; 1998 May; 110(5):767-70. PubMed ID: 9579543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma.
    Wei T; Biskup E; Gjerdrum LM; Niazi O; Ødum N; Gniadecki R
    Oncotarget; 2016 Jul; 7(30):48391-48400. PubMed ID: 27351221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.
    Pham-Ledard A; Prochazkova-Carlotti M; Laharanne E; Vergier B; Jouary T; Beylot-Barry M; Merlio JP
    J Invest Dermatol; 2010 Mar; 130(3):816-25. PubMed ID: 19812605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
    Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-KIT expression in primary cutaneous T-cell lymphomas.
    Brauns TC; Schultewolter T; Dissemond J; Maschke J; Goos M
    J Cutan Pathol; 2004 Oct; 31(9):577-82. PubMed ID: 15330987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunophenotypic studies in cutaneous T-cell lymphomas: clinical implications.
    Ralfkiaer E; Wollf-Sneedorff A; Thomsen K; Vejlsgaard GL
    Br J Dermatol; 1993 Dec; 129(6):655-9. PubMed ID: 8286247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
    Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
    J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymph node classification systems in cutaneous T-cell lymphoma. Evidence for the utility of the Working Formulation of Non-Hodgkin's Lymphomas for Clinical Usage.
    Vonderheid EC; Diamond LW; van Vloten WA; Scheffer E; Meijer CJ; Cashell AW; Hardman JM; Lai SM; Hermans J; Matthews MJ
    Cancer; 1994 Jan; 73(1):207-18. PubMed ID: 8275427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas.
    Tensen CP; Vermeer MH; van der Stoop PM; van Beek P; Scheper RJ; Boorsma DM; Willemze R
    J Invest Dermatol; 1998 Aug; 111(2):222-6. PubMed ID: 9699721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Leroy S; Dubois S; Tenaud I; Chebassier N; Godard A; Jacques Y; Dréno B
    Br J Dermatol; 2001 May; 144(5):1016-23. PubMed ID: 11359391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma.
    Wong HK
    Discov Med; 2013 Sep; 16(87):71-8. PubMed ID: 23998443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe.
    Grob JJ; Horchowski N; Tubiana N; Gabriel B; Gastaut JA; Hassoun J; Jouve I; Carcassone Y; Bonerandi JJ
    Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocosis fungoides--an update on a non-mycotic disease.
    Makdisi J; Friedman A
    J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P53 protein expression in Hodgkin's disease.
    Lauritzen AF; Hou-Jensen K; Ralfkiaer E
    APMIS; 1993 Sep; 101(9):689-94. PubMed ID: 8240788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.